Crossmark

Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis

Crossref DOI link: https://doi.org/10.1136/bmjgh-2023-014630

Published Online: 2024-04-22

Published Print: 2024-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Villa, Simone https://orcid.org/0000-0002-0753-8853
de Colombani, Pierpaolo

Dall’Olio, Lucia

Gargioni, Giuliano

Raviglione, Mario https://orcid.org/0000-0002-9331-2067
Funding

Funding for this research was provided by:

Innovative Medicines Initiative (101007873)

Innovative Medicines Initiative (UNITE4TB)
License Information

License valid from 2024-04-22